Evidence map›Paper›PMID 39936760›Full record

ArticleRevista peruana de medicina experimental y salud publica2025

Rapid spread of the emerging cosmopolitan genotype of dengue virus serotype 2, and expansion of dengue virus serotype 1 genotype V in Peru.

Henri Bailon, Víctor Jimenez, Marco Galarza, Princesa Medrano, Orson Mestanza, Dana Figueroa, Wendy Lizarraga, Iris Silva, Luren Sevilla, Verónica Hurtado and 10 more

Abstract read
In one paragraph

Article in Revista peruana de medicina experimental y salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Henri BailonÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0002-9593-6092
Víctor JimenezÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0001-6547-6999
Marco GalarzaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0002-6547-2354
Princesa MedranoÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0003-4126-7038
Orson MestanzaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0001-7268-0496
Dana FigueroaLaboratorio Nacional de Referencia de Enfermedades Metaxénicas y Zoonosis Virales, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0003-4483-1087
Wendy LizarragaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0003-2595-5674
Iris SilvaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0001-7290-9254
Luren SevillaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0002-9940-1036
Verónica HurtadoÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0003-3667-6806
Vanessa IzarraÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0002-9220-6270
Carlos PadillaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0002-0562-0431
Luis BarcenaÁrea de Innovación y Desarrollo (Equipo de Vigilancia Genómica), Centro Nacional de Salud Pública (CNSP), Instituto Nacional de Salud (INS), Lima, Perú.ORCID http://orcid.org/0000-0001-8776-8888
Omar CaceresLaboratorio Nacional de Referencia de Virus Inmunoprevenibles, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0003-1529-2475
Susy MerinoLaboratorio Nacional de Referencia de Enfermedades Metaxénicas y Zoonosis Virales, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0002-4935-063X
Adolfo MarceloLaboratorio Nacional de Referencia de Enfermedades Metaxénicas y Zoonosis Virales, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0002-0043-5819
Nora RuizLaboratorio Nacional de Referencia de Virus Inmunoprevenibles, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0001-6956-6342
Hapuarachchige Chanditha HapuarachchiiDivisión de Microbiología y Epidemiología Molecular, Instituto de Salud Medioambiental, Agencia Nacional de Medio Ambiente, Singapur.ORCID http://orcid.org/0000-0001-7079-8538
César Cabezas SánchezInstituto Nacional de Salud, Lima, Perú.ORCID http://orcid.org/0000-0001-5120-0713
María P GarcíaLaboratorio Nacional de Referencia de Enfermedades Metaxénicas y Zoonosis Virales, CNSP-INS, Lima, Perú.ORCID http://orcid.org/0000-0002-2185-5038

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMotivation for the study. This study aimed to analyze the prevalence and distribution of the V genotypes of dengue virus type 1 (DENV-1) and the cosmopolitan genotype DENV-2 in Peru, in order to understand their expansion in different regions; since these viruses can cause important outbreaks in the country. Main findings. A rapid spread and wide distribution of the cosmopolitan DENV-2 genotype was reported in Peru in 2022, following its initial introduction in 2019. DENV-1 genotype V, present in Peru since the 1990s, has now expanded to new Peruvian regions, after previously being restricted to rural and jungle areas in the north of the country. Implications. The results highlight the urgent need to strengthen epidemiological and genomic surveillance systems to monitor and control the spread of these genotypes in Peru, allowing a more rapid response and controlling their potential spread to other regions of the Americas. OBJECTIVES.: This study aimed to evaluate the prevalence and distribution of dengue virus genotype V serotype 1 (DENV-1) and cosmopolitan genotype serotype 2 (DENV-2) in Peru between 2019 and 2022. MATERIALS AND METHODS.: The envelope (E) gene region was amplified from 79 serum samples by polymerase chain reaction (PCR) and sequenced by next-generation sequencing (NGS) technology. The obtained sequences were subsequently analyzed with bioinformatics tools. RESULTS.: The study generated envelope gene sequences of DENV-1 and DENV-2 serotypes. Our study revealed a rapid dispersal and wide distribution of the cosmopolitan DENV-2 genotype in several regions of Peru in 2022, as well as the spread of DENV-1 genotype V to new Peruvian regions, along with the cosmopolitan DENV-2 genotype. CONCLUSIONS.: Our findings suggest the urgent need to strengthen epidemiological and genomic surveillance systems to understand and control the spread of circulating DENV genotypes in Peru. This will allow a more rapid response, as well as the monitoring of its potential dissemination to other countries in the Americas.

Indexed as

DengueDengue VirusAdolescentAdultFemaleGenotypeHumansMalePeruPrevalenceSerogroupTime FactorsYoung Adult

Identifiers

PMID39936760
PMCPMC11797585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.